New 'Bedside' cancer therapy trial seeks to tame tough leukemia
NCT ID NCT07277504
Summary
This early-stage study is testing a new, personalized cell therapy made at a patient's bedside to treat a type of adult blood cancer called B-cell acute lymphoblastic leukemia. The main goals are to check if the treatment is safe, find the best dose, and see if it can put the cancer into remission. Up to 50 adults with this leukemia will receive the one-time treatment and be closely monitored for side effects and how well they respond.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA, ADULT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
The General Hospital of Western Theater Command
Chengdu, Sichuan, China
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.